Clinical Trials Browser

Phase 2 × Completed × Fanconi Anemia × Clear all

NCT02873975 2022-10-21

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Phase 2 Completed

27 enrolled 13 charts

Classical hematology

Fanconi Anemia

NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Phase 2 Completed

41 enrolled 13 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00000603 2016-04-14

Cord Blood Stem Cell Transplantation Study (COBLT)

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Fanconi Anemia, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Neoplasms, Severe Combined Immunodeficiency